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Images in Cytopathology
Malignant triton tumor (MTT) is a rare aggressive subtype of malignant peripheral nerve sheath tumor (MPNST) characterized by rhabdomyoblastic differentiation. [1] MTT generally arises from a peripheral nerve in the head, neck, extremities, or trunk. Rare sites include the brain, buttock, viscera, mediastinum, and retroperitoneum. [1] First described in 1932 by Masson and later named by Woodruff et al. in 1973 , histopathological features of MTT have been adequately described in the literature. [2] [3] [4] However, there are only few case reports describing the cytological features of MTT. [5, 6] We report a case of MTT in a 42-year-old male diagnosed on fine needle aspiration cytology (FNAC).
A 42-year-old male presented with a mass in the left lower alveolus. It was progressively increasing in size. The patient gave history of wide local excision of a mass in the same site 1 year back followed by chemotherapy. This initial excision histology was diagnosed as MPNST. He was asymptomatic for 5 months. But then he had a recurrent mass in the site of surgery. On local examination, there was a globular mass measuring 5 × 4 cm in the left lower alveolus extending from the left first premolar to first molar. It was obliterating the left lower gingivobuccal sulcus.
Contrast-enhanced computed tomography showed a heterogeneously enhancing mass measuring 5.5 × 5 × 5 cm in the left lower gingivobuccal sulcus and the adjacent buccal mucosa. The body of the mandible was also involved. The left level IB, II, III, and IV cervical lymph nodes were enlarged. FNAC was performed. Smears were stained for May-Grunwald Giemsa and Papanicolaou (Pap) stains. Smears were richly cellular and showed two types of cells. The predominant cell types were the medium-sized polygonal to spindly cells arranged in pseudopapillaroid clusters and lying singly. These cells had oval nuclei with some having elongated nuclei with smooth contours and inconsistently tapered end. In some cells, nuclei had comma-shaped morphology [ Figure 1a ]. All these cells had finely granular, evenly dispersed nuclear chromatin. The other type of cells was large pleomorphic cells mostly clinging to the pseudopapillaroid clusters and lying discretely [ Figure 1a ]. These cells were oval to pear shaped with eccentrically placed nuclei and moderate to abundant cytoplasm [ Figure 1b ].
Subsequently, immunocytochemistry was performed on the Pap-stained smears without destaining with a panel of S100, desmin, MyoD1, myogenin, cytokeratin, smooth muscle actin, and HMB45. S100 showed both nuclear and cytoplasmic positivity in the medium-sized polygonal to spindly cells focally [ Figure 1c ]. Desmin showed cytoplasmic positivity in large pleomorphic cells. MyoD1 and myogenin showed nuclear positivity in those large cells [ Figure 1d ]. Cytokeratin, smooth muscle actin, and HMB45 were negative. A diagnosis of MTT was offered.
On the basis of cytological diagnosis, the patient underwent wide local excision of the tumor with left hemimandibulectomy and modified radical neck resection [ Figure 1e ]. On histopathological examination, the tumor was composed of spindle cells with good number of pleomorphic cells having eosinophilic cytoplasm [ Figure 1f ]. Some of these cells showed cross striations. Mitosis was brisk with 10/10 high-power field. Thus, the diagnosis of MTT was confirmed. The lymph nodes were free.
Postoperatively, the patient received adjuvant radiotherapy. However, the patient presented with an enlarged left cervical lymph node measuring 4 × 3 cm after 6 months of surgery. FNAC from the lymph node showed similar cytomorphology and a diagnosis of MTT was made. MTT is a rare tumor, which constitutes 5% of all MPNSTs. [1] Most cases are reported in adults with a mean age of about 30 years. [1] However, patients of all ages have been described. MTT can occur in sporadic form or over a setting of neurofibromatosis-1 (NF-1). [1] It is estimated that between 40% and 70% of cases occur in patients with NF-1, with an earlier age of onset and predominantly in male subjects. [1] The sporadic cases are seen in females of older age group. [1] Cytologically, MTT consists of a mixture of two types of tumor cells -the predominant oval to spindle cells and the other large pleomorphic cells. [5, 6] In the present case, the mixture of two tumor cells' population with immunocytochemical features clinched the diagnosis. Immunohistochemically, MTT shows positivity with S100 and Leu-7. [4] The rhabdomyoblastic differentiation is confirmed with positive staining with desmin, myoD1, and myogenin. [4] The important differential diagnoses of MTT are synovial sarcoma, leiomyosarcoma, fibrosarcoma, malignant melanoma, and pleomorphic rhabdomyosarcoma depending on the predominant cell type. [4] Therefore, immunostains are important to confirm the diagnosis. In the present case, cytomorphology along with S100, desmin, MyoD1, and myogenin positivity and cytokeratin, smooth muscle actin, and HMB45 negativity confirmed the diagnosis of MTT.
Malignant Triton Tumor Diagnosed on Fine Needle Aspiration Cytology
There are different hypotheses regarding the histogenesis of MTT. The most widely accepted one is the metaplastic theory, which states that malignant Schwann cells transform directly into striated muscle cells. [2, 4] Chemotherapy may induce rhabdomyoblastic differentiation in sarcomas including MPNST due to tumor differentiation. In the present case, the pathogenesis could be attributed to chemotherapy-induced rhabdomyoblastic differentiation in a diagnosed case of MPNST.
MTT is aggressive, with a poorer prognosis than classical MPNST. [4] The 5-year survival rate of MTT is 3%-10% when compared with 50%-60% for classical MPNST. [6] Thus, MTTs must be differentiated from MPNSTs for prompt and aggressive treatment. Resection of the tumor with wide margins followed by radiotherapy is the recommended treatment. [4, 6] 
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